Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma

Oncolytic Newcastle disease virus (NDV) might be a promising new therapeutic agent for the treatment of pancreatic cancer. We evaluated recombinant NDVs (rNDVs) expressing interferon (rNDV-hIFNβ-F(0)) or an IFN antagonistic protein (rNDV-NS1-F(0)), as well as rNDV with increased virulence (rNDV-F(3a...

Descripción completa

Detalles Bibliográficos
Autores principales: Buijs, Pascal, van Nieuwkoop, Stefan, Vaes, Vincent, Fouchier, Ron, van Eijck, Casper, van den Hoogen, Bernadette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488723/
https://www.ncbi.nlm.nih.gov/pubmed/26110582
http://dx.doi.org/10.3390/v7062756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488723/
https://www.ncbi.nlm.nih.gov/pubmed/26110582
http://dx.doi.org/10.3390/v7062756

Ejemplares similares